Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study - Bigal, M E; Dodick, D W; Rapoport, A M (Lancet Neurol, 2015)